Invention Grant
- Patent Title: Piperidinone carboxamide azaindane CGRP receptor antagonists
- Patent Title (中): 哌啶酮甲酰胺氮杂环丁烷CGRP受体拮抗剂
-
Application No.: US13293186Application Date: 2011-11-10
-
Publication No.: US08481556B2Publication Date: 2013-07-09
- Inventor: Ian M. Bell , Mark E. Fraley
- Applicant: Ian M. Bell , Mark E. Fraley
- Applicant Address: US NJ Rahway
- Assignee: Merck, Sharp & Dohms, Corp.
- Current Assignee: Merck, Sharp & Dohms, Corp.
- Current Assignee Address: US NJ Rahway
- Agent Nicole M. Beeler; Gerard M. Devlin
- Main IPC: C07D471/14
- IPC: C07D471/14 ; C07D471/20 ; A61K31/438 ; A61P25/06
Abstract:
The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
Public/Granted literature
- US20120122911A1 PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS Public/Granted day:2012-05-17
Information query
